Migraine is common in patients with sarcoidosis. Cephalalgia 2018 Dec;38(14):2079-2082
Date
03/28/2018Pubmed ID
29580067DOI
10.1177/0333102418768037Scopus ID
2-s2.0-85045068971 (requires institutional sign-in at Scopus site) 8 CitationsAbstract
OBJECTIVE: To describe the frequency of migraine and predictors of having migraine in sarcoidosis patients.
METHODS: The ID migraine questionnaire was administered to a well-phenotyped observational cohort of sarcoidosis patients (most of whom were seeking specialty care) and healthy controls. Predictors of migraine status were examined using univariate and multivariable logistic regression.
RESULTS: Migraine was seen in 29% of 96 patients with sarcoidosis and 13% of 39 healthy controls, ( p = 0.049). Among those with sarcoidosis, in univariate regression analysis only female sex was predictive of having migraine, and in a multivariable regression female sex remained significant (OR 4.6, 95% CI 1.2-18.2). There was no association between migraine and age, depression, dyspnea, immunosuppression use, or ESR.
CONCLUSIONS: Migraine is a common comorbidity in sarcoidosis patients. As such, better recognition and targeted treatment of migraine has the potential to improve quality of life as part of a comprehensive care plan for sarcoidosis patients.
Author List
Gelfand JM, Gelfand AA, Goadsby PJ, Benn BS, Koth LLMESH terms used to index this publication - Major topics in bold
AdultAged
Comorbidity
Female
Humans
Male
Middle Aged
Migraine Disorders
Risk Factors
Sarcoidosis
Surveys and Questionnaires
